Management of Bone Health in Multiple Myeloma
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Analyze the risks and benefits of intravenous bisphosphonates for the treatment of bone lesions in multiple myeloma
Noopur Raje, MD
Dana-Farber/Brigham and Women's Cancer Center
- 0.50 Participation
- 0.44 Nurse
- 0.50 Pharmacist
- 0.50 Physician